Matchpoint Therapeutics

BiotechnologySeries ACambridge, USmatchpointtx.com

Latest round

Series A

Last raised

Oct 2022

Total raised

$72M

Investors

6

About Matchpoint Therapeutics

Founded in 2021 and based in Massachusetts, US, Matchpoint Therapeutics, Inc. is a biotech company that focuses on the development of covalent medicines. Andre Turenne, the company's president and CEO, served as President and Chief Executive Officer of Voyager Therapeutics and Senior Vice President and Global Head of Business Development & Licensing at Sanofi. The company's key products include covalent drugs and the advanced covalent exploration (ACE) platform. The advanced covalent exploration (ACE) platform. The advanced covalent exploration (ACE) platform provides services such as pathogenic protein identification and proprietary libraries of covalent compounds.

Who invested in Matchpoint Therapeutics

6 investors across 2 rounds

See all investors in Matchpoint Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Oct 5, 2022

    Amount

    $42M

    Investors

    Locked

  2. Seed

    Nov 1, 2021

    Amount

    $30M

    Investors

    Locked

Questions about Matchpoint Therapeutics

Who invested in Matchpoint Therapeutics?

Matchpoint Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Matchpoint Therapeutics raised?

Matchpoint Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Matchpoint Therapeutics last raise money?

Matchpoint Therapeutics's most recent round on record is a Series A, in Oct 2022.

What does Matchpoint Therapeutics do?

Founded in 2021 and based in Massachusetts, US, Matchpoint Therapeutics, Inc.

Where is Matchpoint Therapeutics headquartered?

Matchpoint Therapeutics is headquartered in Cambridge, US.

Which VCs invest in companies like Matchpoint Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Matchpoint Therapeutics's stage. Their profiles are linked below.

Raising like Matchpoint Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.